The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $126.52

Today's change0.00 0.00%
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $126.52

Today's change0.00 0.00%
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc closed at (U.S.)$126.52.

Shares have lost 1.13% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 5.77% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $126.52
  • High--
  • Low--
  • Bid / Ask(U.S.) $122.49 / (U.S.) $131.00
  • YTD % change+0.98%
  • Volume0
  • Average volume (10-day)2,129,343
  • Average volume (1-month)1,580,431
  • Average volume (3-month)1,588,736
  • 52-week range(U.S.) $107.33 to (U.S.) $141.25
  • Beta1.06
  • Trailing P/E25.86×
  • P/E 1 year forward17.14×
  • Forward PEG1.77×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.47%
  • Trailing EPS(U.S.) $4.89
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.69%

Based on its net profit margin of 11.69%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 31, 201412/31/2014Sep 27, 201409/27/2014
Revenue4,2713,9194,4934,171
Total other revenue--------
Total revenue4,2713,9194,4934,171
Gross profit1,9421,8232,0921,934
Total cost of revenue2,3292,0962,4012,238
Total operating expense3,6753,4323,8543,531
Selling / general / administrative1,1681,1621,2241,208
Research & development175166183175
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3846-90
Other operating expenses, total--------
Operating income596487639640
Interest income (expense), net non-operating-103-108-116-117
Gain (loss) on sale of assets--------
Other--------
Income before tax504382537539
Income after tax512385604470
Income tax, total-8-3-6769
Net income512385601472
Total adjustments to net income--------
Net income before extra. items512385604470
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items512385604470
Inc. avail. to common incl. extra. items512385601472
Diluted net income512385601472
Dilution adjustment----0--
Diluted weighted average shares402401404404
Diluted EPS excluding extraordinary itemsvalue per share1.270.961.491.16
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.280.971.570.97